News | Radiopharmaceuticals and Tracers | June 05, 2019

Novel technique enables simultaneous production of molybdenum-99 and other isotopes without the need for highly enriched, weapons-grade uranium

BGN Technologies Introduces Novel Medical Imaging Radioisotope Production Method

June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel method for producing radioisotopes for nuclear medicine and medical imaging technologies such as computed tomography (CT) scan and positron emission tomography-computed tomography (PET-CT).

Developed by Alexander Tsechanski, Ph.D., from the BGU Department of Nuclear Engineering, the new technique obviates the need for highly enriched, weapons-grade uranium and a nuclear reactor. Nuclear medicine often necessitates the use of technetium-99m (Tc-99m) as the isotope for imaging, an unstable technetium isotope with a only a six-hour half-life that requires onsite production. In order to produce it in an economically efficient way, currently it requires weapons-grade, highly enriched uranium and a nuclear reactor to generate molybdenum-99 (Mo-99), which decays into technetium-99m (Tc-99m).

The new invention uses the naturally occurring and stable molybdenum-100 (Mo-100) isotope and a linear electron accelerator to generate Mo-99 and Tc-99m1. This process can also simultaneously generate other short-lived radioisotopes such as F-18, O-15, N-13 and C-11 as byproducts for use in PET scans.

BGN Technologies said it is currently looking for partners for further developing and commercializing the technology.

For more information: www.in.bgu.ac.il

Related Radiopharmaceuticals Content

Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

University of Missouri Research Reactor Files to Start U.S. Production of Medical Isotopes

FDA Clears Path for First Domestic Supply of Tc-99m Isotope

Reference

1. Fedorchenkoa D.V. and Tsechanski A. Photoneutronic aspects of the molybdenum-99 production by means of electron linear accelerators. Nuclear Inst. and Methods in Physics Research B, published online Oct. 23, 2018. https://doi.org/10.1016/j.nimb.2018.10.018


Related Content

News | Proton Therapy

May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the ...

Time May 21, 2024
arrow
News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | Cardiac Imaging

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...

Time April 23, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 10, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time April 10, 2024
arrow
Subscribe Now